The current therapy of multiple sclerosis.

  • D. A. Francis
  • Published 1993 in Journal of clinical pharmacy and therapeutics


The mainstay of treatment for multiple sclerosis in the U.K., and worldwide, remains corticosteroid therapy. High-dose pulses of intravenous methylprednisolone is currently the most favoured agent for acute exacerbations or a sudden acceleration in clinical course. Many patients who follow a more insidious decline rely on symptomatic treatments designed to… (More)